An unknown buyer agreed to acquire London medical facility, Ontario from NeuPath Health Inc. (TSXV:NPTH) on March 15, 2023. The net proceeds from this sale will be invested in the construction of, and move to, NeuPath's new more modern location, and for working capital and general corporate purposes. The transaction is expected to complete on August 1, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 CAD | 0.00% | +8.33% | +5.41% |
03-15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
03-15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.41% | 8.03M | |
+23.20% | 87.77B | |
-27.65% | 70.35B | |
-5.56% | 25.03B | |
+4.17% | 17.73B | |
-15.13% | 16.31B | |
+1.82% | 15.48B | |
+71.58% | 13.52B | |
+75.37% | 13.01B | |
+38.32% | 12.9B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- An unknown buyer agreed to acquire London medical facility, Ontario from NeuPath Health Inc..